The global artificial intelligence in healthcare market is expected to reach a market size of USD 61.59 Billion by 2027 and register a substantially high CAGR over the forecast period, according to a new report by Reports and Data. Artificial intelligence (AI) in healthcare market revenue growth is driven by increasing efficiency in drug discovery and advancement in precision medicine, which is resulting in rising demand and application of these solutions globally. Rise in prevalence of chronic diseases, and increasing global elderly population is expected to continue to support the growth of the market.
Application of artificial intelligence in clinical procedures to check patient’s vital signs, ask required questions, and give prescriptions to patients are accelerating its adoption in technologically advanced region. The technology is also used to give reminders and alert healthcare workers during medical procedures. The advancement in deep learning technology is also propelling the growth for artificial intelligence in healthcare market.
Rising prevalence of complex diseases and need for novel surgery is also driving increasing deployment of artificial intelligence technologies in healthcare sector. However, hesitance among healthcare professionals to adopt artificial intelligence due to some perceived limitations currently is expected to negatively impact growth of the market to a certain extent.
The COVID-19 impact:
COVID-19 outbreak has affected the artificial intelligence (AI) in healthcare market positively. AI is playing a crucial role in dealing with the pandemic. The application of artificial intelligence in healthcare has exploded as several biopharmaceuticals and government companies are deploying the technology to study the virus and develop an effective vaccine. It is also helping in managing the information through personalized learning and information.
Top Companies Profiled in the Report Include: Microsoft Corporation, Intel Corporation, IBM, Amazon Web Services, Intel Corporation, Johnson & Johnson Services, Inc., Siemens Healthineers, General Electric, Google Inc., and Medtronic plc, among others.
The pharma and healthcare industry has undergone a revolutionary change owing to the COVID-19 pandemic with individuals increasing their focus on health and wellness. Companies operating in the industry have invested heavily in clinical trials and research studies to develop medications to cater to the growing unmet clinical demand on a global level. Implementation of cutting-edge technology in healthcare sector and increasing investment in research and development have contributed significantly to revenue growth of the market in the recent past. In addition, availability of favorable health insurance and reimbursement policies have also positively impacted the healthcare sector with more and more individuals opting to get treatment at hospital and clinical facilities. Rapid development of novel drugs and pharmaceuticals, increasing incidence of lifestyle and chronic diseases, establishment of state-of-the-art healthcare facilities, and rising availability of over-the-counter medications have significantly contributed to the revenue growth of the market.